These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 136918)
1. Adverse effects of practolol. Nicholls JT Ann Clin Res; 1976 Aug; 8(4):229-31. PubMed ID: 136918 [No Abstract] [Full Text] [Related]
2. [Adverse effects of practolol]. Ahonen A Duodecim; 1976; 92(22):1264-5. PubMed ID: 137109 [No Abstract] [Full Text] [Related]
3. Eye and skin reactions precede practolol peritonitis. Idänpään-Heikkilä JE; Hästbacka J; Järvinen HJ Lancet; 1977 Dec 24-31; 2(8052-8053):1354. PubMed ID: 74720 [No Abstract] [Full Text] [Related]
4. Letter: Report on adverse reactions associated with practolol. Proctor CR Med J Aust; 1974 Nov; 2(20):758. PubMed ID: 4280498 [No Abstract] [Full Text] [Related]
5. [Oculocutaneous reactions following treatment with betablockers]. Erikssen J Tidsskr Nor Laegeforen; 1976 Aug; 96(24):1288-9. PubMed ID: 9706 [No Abstract] [Full Text] [Related]
6. [Actual late effects. Skin, eye and hearing changes during treatment with practolol (Eraldin)]. Ugeskr Laeger; 1975 Apr; 137(18):1016-7. PubMed ID: 124969 [No Abstract] [Full Text] [Related]
7. Cutaneous reactions to practolol. Clinical and histopathological study. Kauppinen K; Niemi KM; Salo OP Ann Clin Res; 1976 Aug; 8(4):232-40. PubMed ID: 136919 [TBL] [Abstract][Full Text] [Related]
8. Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Behan PO; Behan WM; Zacharias FJ; Nicholls JT Lancet; 1976 Nov; 2(7993):984-7. PubMed ID: 62263 [TBL] [Abstract][Full Text] [Related]
9. Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome. Amos HE; Lake BG; Artis J Br Med J; 1978 Feb; 1(6110):402-4. PubMed ID: 146533 [TBL] [Abstract][Full Text] [Related]
10. Letter: Skin reactions to practolol. Wright P Br Med J; 1974 Jun; 2(5918):560. PubMed ID: 4276108 [No Abstract] [Full Text] [Related]
11. Ocular disorders resulting from treatment with practolol (Eraldin) [proceedings]. Cruysberg JR; Pinckers A Ophthalmologica; 1977; 175(1):39-40. PubMed ID: 904900 [No Abstract] [Full Text] [Related]
12. Practolol and the safety of other beta blockers. Sutherland DC; Wilson JD N Z Med J; 1976 Oct; 84(573):282-5. PubMed ID: 12491 [TBL] [Abstract][Full Text] [Related]
14. [Letter: Skin reactions due to practolol]. Marghescu S Hautarzt; 1975 Dec; 26(12):663. PubMed ID: 1213887 [No Abstract] [Full Text] [Related]
15. Practolol-induced autoantibodies and their relation to oculo-cutaneous complications. Jachuck SJ; Stephenson J; Bird T; Jackson FS; Clark F Postgrad Med J; 1977 Feb; 53(616):75-7. PubMed ID: 141660 [TBL] [Abstract][Full Text] [Related]
16. [From The committee for the Registration of Adverse Effects. Adverse effects following Eraldin therapy]. Lunde I; Borchgrevink CF Tidsskr Nor Laegeforen; 1975 Oct; 95(28):1609. PubMed ID: 1179394 [No Abstract] [Full Text] [Related]
17. Practolol and the nephrotic syndrome. Farr MJ; Wingate JP; Shaw JN Br Med J; 1975 Apr; 2(5962):68-9. PubMed ID: 1131550 [No Abstract] [Full Text] [Related]
18. Aggravation of psoriasis and occurrence of psoriasiform cutaneous eruptions induced by practolol (Eraldin). Sondergaard J; Wadskov S; Jensen HA; Mikkelsen HI Acta Derm Venereol; 1976; 56(3):239-43. PubMed ID: 59510 [TBL] [Abstract][Full Text] [Related]
19. Oculocutaneous reaction to oxprenolol. Holt PJ; Waddington E Br Med J; 1975 Jun; 2(5970):539-40. PubMed ID: 125135 [No Abstract] [Full Text] [Related]